The study identifies NEURL4, a mitochondrial ADP-ribosyltransferase enzyme, which plays a critical role in maintaining mitochondrial DNA integrity. The research suggests potential new strategies for treating diseases with a mitochondrial component, such as cancer, diabetes, and neurodegenerative disorders.
Researchers at Uppsala University have designed a molecule that inhibits the replication of coronaviruses, including the new variant, with great potential for developing an antiviral drug. The molecule has been shown to be effective against both old and new variants, offering hope for treatment options.
Researchers at the University of Gothenburg mapped SARS-CoV-2 mutation patterns and found that ADAR1-induced mutations weaken the virus. These mutations are more common than other types of mutations, suggesting a protective mechanism against COVID-19.
Researchers have imaged an enzyme involved in carbapenem biosynthesis, shedding light on the process of creating a potent side chain that makes these antibiotics effective against antibiotic-resistant bacteria. The discovery could lead to improved antibiotics and new strategies for combating bacterial resistance.
University of Warwick scientists developed a new method to produce indolic amides, carboxylic acids, and auxins using enzymes that mimic plant production. The process is reusable, produces minimal waste products, and could help make pharmaceutical and agrochemical manufacturing more environmentally friendly.
A University of Oklahoma chemist is engineering a sustainable method for producing valuable compounds found in nature, such as cannabinoids and squalenes, using enzymes and E. coli. This approach avoids the environmental and economic challenges associated with traditional plant-based methods.
Researchers at WEHI identified an enzyme in the thymus that is essential for immune T cells to correctly identify threats, safeguarding them from going rogue and attacking healthy tissue. The enzyme KAT7 activates thousands of genes required for 'training' immune T cells not to attack healthy tissue.
The study found that efficient metabolic processes and recycling of components used by the enzyme RuBisCO significantly speed up photosynthesis in Chlorella ohadii. This discovery could lead to improving photosynthesis efficiency in other plants, developing new engineering tools for sustainable food production.
An international team led by the University of Ottawa has published findings on the importance of the enzyme GCN5 in maintaining muscle integrity. The study discovered that GCN5 plays a crucial role in boosting the expression of key structural proteins, notably dystrophin.
Researchers at Waseda University discovered a new protein isoform called Senp5S, which helps regulate Drp1 and mitochondrial dynamics during brain development. The study suggests a novel and vital role for post-translational SUMOylation in neuronal differentiation.
Scientists at La Jolla Institute for Immunology have discovered a link between TET enzyme deficiency and the formation of unusual DNA structures, such as G-quadruplexes and R-loops, which contribute to genomic instability. The study suggests that regulating these structures may be key to controlling cancer development.
A new study reveals the sophisticated mechanism by which adenoviruses infect human cells and transfer foreign DNA into their nucleus. Protein V plays a crucial role in increasing the virus particle's stability and preventing premature DNA release, which triggers an anti-viral alarm system.
Researchers at Weill Cornell Medicine discovered that deleting the EtfD Mtb enzyme renders Mycobacterium tuberculosis unable to sustain an infection in mice. The enzyme plays a critical role in fatty acid breakdown, making it an attractive target for TB treatment.
Researchers at RIKEN have developed a healthier form of tapioca starch by suppressing multiple genes that increase its resistance to digestion. The resulting starch is composed of longer chains with fewer branches, making it harder to digest and potentially improving intestinal function and blood sugar control.
A study found a strong correlation between the number of microbial enzymes that can degrade plastic and local levels of plastic pollution. Researchers analyzed environmental DNA samples from around the world and discovered over 30,000 enzyme homologues with potential to break down various types of plastics.
New research suggests that cannabis use can lead to harmful drug-drug interactions by interfering with two families of enzymes that metabolize a wide range of drugs. This could result in unintended side effects such as toxicity or accidental overdose, particularly for older individuals using medications.
Scientists have developed an enzyme that degrades the capsule surrounding the bacterium that causes anthrax, reducing virulence and protecting mice from infection. The treatment, known as PEG-CapD-CPS334C, is a promising avenue for treating multidrug-resistant anthrax and other bacterial infections.
Researchers discovered that eliminating α-endosulfine (ENSA) or blocking its function reduces brain changes and improves memory in mice. ENSA blocks a potassium channel, which, when blocked, combats excess ENSA levels associated with Alzheimer's disease.
Researchers from the University of Manchester have discovered a new way to manipulate key assembly line enzymes in bacteria using CRISPR-cas9 gene editing. This approach could lead to the production of improved antibiotics with potentially improved properties, addressing the growing threat of antimicrobial resistance.
Researchers genetically engineer E. coli microbes to convert glucose into olefins, a type of hydrocarbon found in gasoline, using a two-step process with a catalyst. This method has potential to advance green energy technology and create sustainable biofuels.
Researchers have designed a digital camera-based system that can accurately detect jaundice in newborns within one second, sending diagnoses to carers via SMS. The system uses image processing techniques to detect bilirubin levels, triggering blue LED phototherapy and treatment.
Scientists identified multiple enzymes involved in C-glycoside metabolism, revealing a common reaction mechanism in both intestinal and soil bacteria. This discovery could provide insight into how the body breaks down these molecules and potentially lead to new treatments for diseases.
Scientists have engineered enzymes to manufacture molnupiravir, resulting in a shorter and higher-yielding synthesis. The new method reduces the risk of hospitalization and death from COVID-19 for newly diagnosed patients, showing promise as an antiviral treatment.
Researchers found that optimal cellular efficiency occurs when substrate mass equals free enzyme waiting to convert it into products. This relationship was confirmed with E. coli experimental data, offering insights into biochemistry and cellular physiology.
A study by the University of Pennsylvania and Indiana University found that a nanozyme therapy, combining ferumoxytol and hydrogen peroxide, significantly reduced the buildup of harmful dental plaque and targeted bacteria responsible for tooth decay. The treatment effectively killed Streptococcus mutans bacteria while leaving other ora...
Researchers discovered that an insect digestive enzyme removes sugar from a plant defense compound, promoting larva growth on dandelion plants containing the compound. This process also leads to the larva avoiding plants with high concentrations of the compound.
Researchers at Ural Federal University developed an ultra-sensitive sensor to analyze honey for nitrobenzene, a toxic compound. The sensor's exceptional accuracy and low sample requirements make it suitable for on-site analysis.
Researchers at IOCB Prague have created a glowing DNA enzyme called Supernova, which catalyzes a chemiluminescent reaction. This breakthrough uses artificial evolution to identify light-producing deoxyribozymes in a vast library of DNA molecules, opening up new possibilities for point-of-care assays and high-throughput screens.
Researchers at Berkeley Lab have successfully engineered microbes to produce novel chemicals and developed a new technique for studying enzyme reactions in real-time. This breakthrough could lead to the production of sustainable fuels, pharmaceuticals, and renewable plastics.
Researchers at the University of Copenhagen have discovered that the BRCA2 gene requires a specific enzyme, PP2A-B56, to repair DNA damage. This finding may pave the way for more targeted treatment of cancer patients with certain mutations.
A research team at Iowa State University aims to create more robust microbes that can produce heat- and acid-resistant enzymes, improving the bioproduction of fuels and chemicals. The goal is to make industrial fermentation more efficient and cost-effective.
Researchers at TTUHSC have identified novel targets for treating stroke, focusing on enhancing neurolysin activity. The study discovered small molecules that can selectively enhance the activity of neurolysin, which showed promise in reducing damage to the brain after a stroke.
Researchers at WVU will explore how a specific enzyme protects the brain from stroke effects and aging. Their findings may indicate a potential target for medications improving brain blood vessel function after a stroke.
A new study by Oxford academics found that approximately 20% of flies and cockroaches carry carbapenem resistance, while 70-80% carry extended spectrum cephalosporin resistance. Climate change could lead to a doubling of insect populations and an increase in the global spread of antibiotic resistance.
Researchers at DTU Health Tech have invented a one-pot assay, NISDA, for rapid detection of SARS-CoV-2 RNA without the need for enzyme-based methods. The assay detects low concentrations of RNA in 30 minutes and has shown high accuracy and sensitivity.
Scientists have developed a method to produce strigolactones, a group of plant hormones that prevent excessive budding and branching. By combining yeast and bacteria, researchers can synthesize these hormones from microbes, providing a promising alternative to traditional methods.
Research reveals how genetic mutations in aminoacyl-tRNA synthetases cause CMT by halting protein production and inducing integrated stress response. The study's findings provide new avenues for therapies against the disease.
Researchers at Penn State have imaged a protein facilitating RNA modification, allowing them to reconstruct the process. The study reveals how a chemical tag is added to tRNA, improving its ability to translate messenger RNA into proteins.
Researchers discovered a massive enzyme complex in methanogenic archaea that directly transfers electrons from electron bifurcation to CO2 reduction, increasing efficiency. This finding may lead to sustainable biotechnological development and reduce greenhouse gas emissions.
Researchers developed an AI tool that can quickly and accurately identify suspicious proteins in the body by analyzing their movements. The method, known as diffusional fingerprinting, uses machine learning algorithms to predict protein behavior with over 90% accuracy.
A new study reveals evidence of beer drinking 9,000 years ago in southern China, with ancient pots found at a burial site containing residues consistent with beer fermentation. The discovery suggests that ritualized drinking played a significant role in forging social relationships and cooperation among ancient communities.
A study reveals the biological process used by Xanthomonas to weaken plants' defense systems and discovers a novel class of enzymes called CE20 that can assist infection. This discovery contributes to developing strategies to combat citrus canker and obtaining advanced sugars from agroindustrial waste.
Scientists at Tokyo University of Science discovered endophytic bacteria that can survive extreme conditions within passion fruit seeds. The bacteria were isolated from seedlings grown from cut seeds and found to possess biocatalytic activities related to the metabolism of secondary metabolites, such as resveratrol and piceatannol.
Researchers have uncovered a weakness in the key enzyme that solid tumour cancer cells rely on to adapt and survive when oxygen levels are low. Inhibiting this enzyme, called Carbonic Anhydrase IX (CAIX), can effectively stop cancer cell growth.
Researchers used evolutionary 'time travel' to study an ancient enzyme from archaea, finding a universal NTP binding motif that could be used for novel enzyme design. The study also revealed how the human version of the enzyme evolved over time.
A preclinical study found that age-related decline in two sirtuin enzymes alters mitochondrial dynamics, weakening cardiac contractions in response to ischemia-reperfusion injury. Boosting SIRT1/SIRT3 levels may help protect against such injuries, potentially reducing heart attack complications and deaths.
Researchers found a mutation in ELOVL4 enzyme impairs communication between neurons, leading to impaired motor control and coordination. The study provides new insights into the essential role of ELOVL4 in motor function and synaptic plasticity, suggesting potential therapeutic strategies for patients with spinocerebellar ataxia.
A study by UCI researchers reveals two ways APOBEC3A is controlled in response to stress, offering potential therapeutic strategies against cancers and viral infections. The findings could lead to new treatments that prevent DNA mutations caused by the enzyme, reducing disease progression and resistance.
Researchers discover a new way for an antiviral enzyme to detect and destroy viruses that hide inside cell membranes. The OAS1 p46 isoform enhances the immune response against SARS-CoV-2, flaviviruses, and other RNA viruses.
Researchers have discovered an enzyme that enables the accumulation of p-hydroxybenzoic acid in plant cell walls, a potential game-changer for sustainable industrial chemical production. By controlling the expression of this enzyme, plants can be engineered to produce more of this valuable chemical building block.
Researchers discovered an enzyme from Amazon fungus Trichoderma harzianum capable of breaking down diverse plant biomass sugars, enhancing the efficiency of second-generation ethanol production. The enzyme's industrial use is now viable at low cost due to genetic engineering techniques.
The KAUST Metagenomic Analysis Platform (KMAP) enables researchers worldwide to analyze massive microbial data, eliminating the need for advanced bioinformatics skills. KMAP allows scientists to identify proteins and enzymes with potential applications in various industries, such as agriculture and pharmaceuticals.
The anammox bacterium uses the nitrite oxidoreductase enzyme (NXR) to convert toxic nitrite into nitrate, a crucial process in nature's nitrogen cycle. Researchers have now mapped the molecular structure of NXR, gaining insight into its complex structure and organization within the cell.
Researchers discovered that symbiotic bacteria living in shipworms' gills do not have the enzymes to break down lignin, a thick and difficult-to-digest layer of cellulose. Despite this finding, scientists are still trying to figure out what within the shipworm could be responsible for breaking down lignin.
Researchers have produced detailed molecular blueprints of the bacterial enzyme Lit, which may enable bacteria to evade the immune response and contribute to antibiotic resistance. The study's findings could lead to the development of new antibiotics targeting this enzyme.
Researchers developed hybrid enzyme catalysts using a de novo approach to expand biocatalysis, improving stability and activity. The method involves introducing defects into MOFs to alleviate diffusional restrictions and facilitating access of substrates to encapsulated enzymes.
Researchers have engineered an enzyme to bind to and degrade plastic particles, potentially helping to resolve the issue of complete recycling of PET in industry. The enzyme, called PET2, was found to accelerate the reaction between PET's chemical components and water when positive charges were introduced on its surface.
Researchers at St. Jude Children's Research Hospital identified a metabolic control pathway that regulates T follicular helper cells, offering targets for drugs to stimulate the adaptive immune response and treat autoimmune diseases such as lupus. The finding holds promise for developing new vaccines and treatments.
Rice University scientists have isolated a biocatalyst that controls the chirality of compounds, enabling more accurate drug synthesis. The discovery could lead to improved pharmaceutical production by providing a new tool for controlling stereochemistry.
Researchers discovered ethane-eating microbes at hydrothermal vents, which use the same enzyme as methane-eaters to break down ethane. The enzyme's unique structure was visualized with unprecedented precision, revealing a larger catalytic chamber and additional methyl groups, allowing for efficient recognition of ethane.